Xin Lin

879 total citations
31 papers, 628 citations indexed

About

Xin Lin is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xin Lin has authored 31 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xin Lin's work include Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (8 papers) and RNA modifications and cancer (8 papers). Xin Lin is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (8 papers) and RNA modifications and cancer (8 papers). Xin Lin collaborates with scholars based in China, United States and Sweden. Xin Lin's co-authors include Liqiang Zhou, Yi‐Wu Yuan, Chuan Liu, Qi Zhou, Li Liu, Jian Wen, Lu Han, Yao Xu, Xinming Yin and Yue Fang and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and British Journal of Cancer.

In The Last Decade

Xin Lin

28 papers receiving 624 citations

Peers

Xin Lin
Jinsong Wang China
Dawei Zheng China
Yuanda Cheng China
Shaoqing Ju China
Sercan Ergün Türkiye
Bijun Cui China
Jinsong Wang China
Xin Lin
Citations per year, relative to Xin Lin Xin Lin (= 1×) peers Jinsong Wang

Countries citing papers authored by Xin Lin

Since Specialization
Citations

This map shows the geographic impact of Xin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Lin more than expected).

Fields of papers citing papers by Xin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Lin. The network helps show where Xin Lin may publish in the future.

Co-authorship network of co-authors of Xin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Lin. A scholar is included among the top collaborators of Xin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Lin. Xin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Mingxuan, et al.. (2025). Integrated HRI and lean digital healthcare approach for facial paralysis rehabilitation via exoskeletons and smartphone applications. Industrial Management & Data Systems. 125(8). 2486–2507.
2.
Chen, Yichi, Xin Lin, Bolin Wu, et al.. (2025). Ultrasound-responsive nanobubble-mediated sonodynamic therapy sensitizes disulfidptosis in the treatment of liver hepatocellular carcinoma. Ultrasonics Sonochemistry. 118. 107368–107368. 1 indexed citations
3.
Lin, Xin, Hongyu Cheng, Biao Dong, et al.. (2025). Systematic analyses uncover robust salivary microbial signatures and host-microbiome perturbations in oral squamous cell carcinoma. mSystems. 10(2). e0124724–e0124724. 5 indexed citations
4.
Yuan, Yi‐Wu, et al.. (2024). Ferroptosis and its current progress in gastric cancer. Frontiers in Cell and Developmental Biology. 12. 1289335–1289335. 6 indexed citations
5.
Lin, Xin, Chenxi Liu, Hao Lu, et al.. (2024). Methionine restriction promotes cisplatin sensitivity of gastric cancer resistant cells by down-regulating circ-CDK13 level. Experimental Cell Research. 443(1). 114315–114315. 1 indexed citations
6.
Gaffney, Christopher, Emily Vertosick, Sigrid Carlsson, et al.. (2023). A brief mind-body intervention to reduce pain and anxiety during prostate needle biopsy: a clinically integrated randomized controlled trial with 2-staged consent. Urologic Oncology Seminars and Original Investigations. 41(12). 484.e1–484.e5. 4 indexed citations
7.
Liu, Zhi‐Yang, Yihe Li, Bowen Li, & Xin Lin. (2023). Development and validation of a vesicle-mediated transport-associated gene signature for predicting prognosis and immune therapy response in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 149(14). 13211–13230. 2 indexed citations
8.
Zhou, Qi, Yi‐Wu Yuan, Lu Hao, et al.. (2023). Cancer functional states-based molecular subtypes of gastric cancer. Journal of Translational Medicine. 21(1). 80–80. 7 indexed citations
9.
Han, Lu, Xin Lin, Qun Yan, et al.. (2022). PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells. Oncogene. 41(13). 1851–1865. 37 indexed citations
10.
Zhou, Liqiang, et al.. (2021). Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets. Cancer Medicine. 10(10). 3309–3322. 15 indexed citations
11.
Lin, Xin, Hao Lu, Chuan Liu, et al.. (2021). Methionine deficiency promoted mitophagy via lncRNA PVT1-mediated promoter demethylation of BNIP3 in gastric cancer. The International Journal of Biochemistry & Cell Biology. 141. 106100–106100. 23 indexed citations
12.
13.
Zhou, Liqiang, et al.. (2021). Establishment of a prognostic model of ten transcription factors in gastric cancer. Genomics. 113(6). 4075–4087. 4 indexed citations
14.
Clements, Matthew, Xin Lin, Emily Vertosick, et al.. (2021). Assessing Quality and Safety of an Advanced Practice Provider-Led Active Surveillance Clinic for Men with Prostate Cancer. Urology Practice. 8(5). 535–540. 1 indexed citations
15.
Gu, Chun-Cai, Jianqun Cai, Zhijun Xu, et al.. (2019). MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling. Cell Death and Disease. 10(10). 739–739. 83 indexed citations
16.
Lin, Xin, Qi Zhou, Yi‐Wu Yuan, et al.. (2019). METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy. Journal of Cancer Research and Clinical Oncology. 145(10). 2507–2517. 70 indexed citations
17.
Lin, Xin, et al.. (2018). METase promotes cell autophagy via promoting SNHG5 and suppressing miR-20a in gastric cancer. International Journal of Biological Macromolecules. 122. 1046–1052. 26 indexed citations
18.
19.
Deng, Shengqiong, Qian Zhao, Lixiao Zhen, et al.. (2017). Neonatal Heart-Enriched miR-708 Promotes Proliferation and Stress Resistance of Cardiomyocytes in Rodents. Theranostics. 7(7). 1953–1965. 52 indexed citations
20.
Yang, Xiaobing, Xin Lin, Tao Lu, et al.. (2015). Fasting Plasma Glucose Levels Predict Steroid-Induced Abnormal Glucose Metabolism in Patients with Non-Diabetic Chronic Kidney Disease: A Prospective Cohort Study. American Journal of Nephrology. 41(2). 107–115. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinsong Wang Breakdown of academic impact, for papers by Dawei Zheng Breakdown of academic impact, for papers by Yuanda Cheng Breakdown of academic impact, for papers by Shaoqing Ju Breakdown of academic impact, for papers by Sercan Ergün Breakdown of academic impact, for papers by Bijun Cui
Rankless by CCL
2026